Advisors Asset Management Inc. Acquires 3,259 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Advisors Asset Management Inc. raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.5% during the first quarter, Holdings Channel.com reports. The fund owned 29,412 shares of the biotechnology company’s stock after buying an additional 3,259 shares during the period. Advisors Asset Management Inc.’s holdings in Axon Enterprise were worth $9,202,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Avantax Advisory Services Inc. raised its holdings in Axon Enterprise by 0.8% during the first quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock valued at $1,659,000 after acquiring an additional 40 shares during the period. Brookstone Capital Management raised its holdings in Axon Enterprise by 5.1% during the first quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after acquiring an additional 41 shares during the period. HB Wealth Management LLC increased its holdings in shares of Axon Enterprise by 3.9% in the fourth quarter. HB Wealth Management LLC now owns 1,139 shares of the biotechnology company’s stock worth $294,000 after purchasing an additional 43 shares during the last quarter. Envestnet Portfolio Solutions Inc. increased its holdings in shares of Axon Enterprise by 1.1% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 3,997 shares of the biotechnology company’s stock worth $1,033,000 after purchasing an additional 43 shares during the last quarter. Finally, UMB Bank n.a. increased its holdings in shares of Axon Enterprise by 11.0% in the fourth quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock worth $115,000 after purchasing an additional 44 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. Barclays lifted their target price on Axon Enterprise from $308.00 to $381.00 and gave the stock an “overweight” rating in a report on Wednesday, May 8th. Needham & Company LLC reaffirmed a “buy” rating and set a $400.00 price target on shares of Axon Enterprise in a research note on Tuesday, May 7th. JMP Securities reaffirmed a “market outperform” rating and set a $375.00 price target on shares of Axon Enterprise in a research note on Tuesday, May 7th. Craig Hallum lifted their price target on shares of Axon Enterprise from $325.00 to $370.00 and gave the company a “buy” rating in a research note on Tuesday, May 7th. Finally, Jefferies Financial Group began coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $342.54.

Axon Enterprise Stock Down 0.1 %

NASDAQ:AXON traded down $0.22 during trading hours on Friday, reaching $310.59. The company’s stock had a trading volume of 347,880 shares, compared to its average volume of 488,656. The stock has a 50 day moving average price of $294.06 and a two-hundred day moving average price of $291.32. The company has a market capitalization of $23.44 billion, a P/E ratio of 90.88, a price-to-earnings-growth ratio of 7.06 and a beta of 0.95. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.55 and a current ratio of 2.91. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $329.87.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.20. The business had revenue of $460.74 million for the quarter, compared to the consensus estimate of $441.57 million. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The business’s quarterly revenue was up 34.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.51 earnings per share. Equities analysts predict that Axon Enterprise, Inc. will post 2.35 EPS for the current fiscal year.

Insider Transactions at Axon Enterprise

In other news, Director Jeri Williams sold 308 shares of the company’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total transaction of $95,501.56. Following the transaction, the director now directly owns 1,607 shares of the company’s stock, valued at $498,282.49. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, Director Julie A. Cullivan sold 478 shares of the business’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $286.04, for a total transaction of $136,727.12. Following the sale, the director now directly owns 5,546 shares of the company’s stock, valued at $1,586,377.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jeri Williams sold 308 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total transaction of $95,501.56. Following the sale, the director now directly owns 1,607 shares in the company, valued at $498,282.49. The disclosure for this sale can be found here. Over the last three months, insiders have sold 89,447 shares of company stock valued at $27,684,677. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.